Abingdon Health (LON:ABDX) Releases Earnings Results

Abingdon Health (LON:ABDX) released its quarterly earnings data on Tuesday. The company reported GBX (0.51) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Abingdon Health had a negative return on equity of 55.91% and a negative net margin of 33.88%.

Abingdon Health Trading Up 0.6%

Shares of LON ABDX traded up GBX 0.05 during midday trading on Thursday, reaching GBX 9.05. 571,644 shares of the stock were exchanged, compared to its average volume of 237,414. The company has a 50 day simple moving average of GBX 10.70 and a 200 day simple moving average of GBX 10.53. The stock has a market capitalization of £22.87 million, a P/E ratio of -11.17 and a beta of 0.13. The company has a debt-to-equity ratio of 15.05, a quick ratio of 1.96 and a current ratio of 1.91. Abingdon Health has a twelve month low of GBX 5.50 and a twelve month high of GBX 13.

About Abingdon Health

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.